Intravitreal bevacizumab and ranibizumab injections for patients with polypoidal choroidal vasculopathy

PURPOSE: To compare the effectiveness of intravitreal injection of bevacizumab and ranibizumab in patients with treatment-naïve polypoidal choroidal vasculopathy (PCV). METHODS: A total of 66 and 60 eyes of 121 consecutive patients who received intravitreal bevacizumab (1.25 mg) or ranibizumab (0.5 ...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Cho, H J, Kim, J W, Lee, D W, Cho, S W, Kim, C G
Formato: Artigo
Lenguaje:Inglês
Publicado: Nature Publishing Group 2012
Materias:
Clinical Study
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3298981/
https://ncbi.nlm.nih.gov/pubmed/22173075
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/eye.2011.324
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares